An Israeli venture capital company plans to dramatically ramp up its spending on medical technology start-ups and provide further funding for its investee companies with products in the market that can help contain coronavirus.
Read more here.
An Israeli venture capital company plans to dramatically ramp up its spending on medical technology start-ups and provide further funding for its investee companies with products in the market that can help contain coronavirus.
Read more here.
![[OurCrowd in Jerusalem Post] 86-year-old Copaxone creator has no intention of slowing down](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
